Guardant Health Inc.

Last updated September 27, 2026

Organization details

Legal name
Guardant Health Inc.
Ownership
Public
Status
Active
Headquarters country
United States
Ticker symbol
GH
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001576280

Board of directors

Chief executives

Helmy Eltoukhy · Co-Chief Executive Officer
Dates unknown
AmirAli Talasaz · Co-Chief Executive Officer
Dates unknown

Board connections

7 of this board's directors also sit on 14 other boards.

Network of Guardant Health Inc.'s board connections BioMarin Pharmaceutical Inc. BioMarin Pharmaceutica... Bristol-Myers Squibb Company Bristol-Myers Squibb C... Corvus Pharmaceuticals Inc. Corvus Pharmaceuticals... Denali Therapeutics Inc. Denali Therapeutics In... Ginkgo Bioworks Holdings Inc. Ginkgo Bioworks Holdin... GoodRx Holdings Inc. GoodRx Holdings Inc. Kyverna Therapeutics Inc. Kyverna Therapeutics I... Olema Pharmaceuticals Inc. Olema Pharmaceuticals... Planet Labs PBC Planet Labs PBC Pliant Therapeutics Inc. Pliant Therapeutics In... Takeda Pharmaceutical Company Limited Takeda Pharmaceutical... Tectonic Therapeutic Inc. Tectonic Therapeutic I... Teva Pharmaceutical Industries Limited Teva Pharmaceutical In... The Boston Beer Company Inc. The Boston Beer Compan... Ian T. Clark Ian T. Clark Medina Manuel Hidalgo Medina Manuel Hidalg... Meghan Joyce V Meghan Joyce V Myrtle S. Potter Myrtle S. Potter Roberto Mignone Roberto Mignone Steve E. Krognes Steve E. Krognes Vijaya Gadde Vijaya Gadde Guardant Health Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$78,456
1 purchase by 1 insider
Sold, last 12 months
$164,220,795
133 sales by 14 insiders
Date Insider Transaction Shares Price Value
Aug 17, 2026 Medina Manuel Hidalgo Director Option exercise +232 — —
Aug 17, 2026 Musa Tariq Director Open-market sale −116 $156.45 $18,148
Aug 15, 2026 Musa Tariq Director Option exercise +250 — —
Aug 12, 2026 Monroe Terilyn J. Officer (Chief People Officer) Option exercise +32,288 $20.14 $650,280
Aug 12, 2026 Monroe Terilyn J. Officer (Chief People Officer) Option exercise +14,012 $28.61 $400,883
Aug 12, 2026 Monroe Terilyn J. Officer (Chief People Officer) Open-market sale −3,704 $163.41 $605,286
Aug 12, 2026 Monroe Terilyn J. Officer (Chief People Officer) Open-market sale −9,934 $164.27 $1,631,870
Aug 12, 2026 Monroe Terilyn J. Officer (Chief People Officer) Open-market sale −19,014 $165.16 $3,140,310
Aug 12, 2026 Monroe Terilyn J. Officer (Chief People Officer) Open-market sale −13,248 $166.11 $2,200,584
Aug 12, 2026 Monroe Terilyn J. Officer (Chief People Officer) Open-market sale −400 $167.92 $67,168
Aug 11, 2026 Helmy Eltoukhy Director, Officer (Co-Chief Executive Officer) Gift −35,000 — —
Aug 11, 2026 Helmy Eltoukhy Director, Officer (Co-Chief Executive Officer) Gift +35,000 — —
Aug 10, 2026 Freeman Chris Officer (Chief Commercial Officer) Option exercise +35,412 $110.49 $3,912,672
Aug 10, 2026 Saia John G. Officer (Chief Legal Officer) Gift −800 — —
Aug 10, 2026 AmirAli Talasaz Director, Officer (Co-Chief Executive Officer) Gift −75,000 — —

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.